Serious side effects are rare but can occur
From metabolites to medicines: discovery metabolomics to drive GLP-1 therapy innovation Discovery metabolomics offers a powerful tool to comprehensively explore metabolite and lipid profile changes induced by GLP-1 agonists
Epidemiological data consistently indicate the most substantial risk reduction for cognitive decline related to vascular and metabolic factors (Wang et al., 2025)
The relationship between obesity, metabolic health, and fertility has been well established for many years, Philip Werthman, MD, board-certified urologist, mens health specialist, and director of the Center for Male Reproductive Medicine and Vasectomy Reversal in Los Angeles, CA, who was not involved in the study, told MNT
Heres why people seek out this approach: Weight management & maintenance: Many clients use low dose GLP-1s after reaching their weight loss goal to help maintain results without the intensity of higher doses